BCL2 and psoriasis: Similarly, the pro-apoptotic marker Bax was found to be upregulated in psoriasis samples, with levels increasing to 2.9 compared to the normal range of 1, while the anti-apoptotic marker Bcl-2 was downregulated to 0.3.